All the news Showing 10 of 26 articles from: CirrhosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines Keith Alcorn / 16 November 2021 People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ... New tool to predict outcomes in cirrhosis of the liver Baylor College of Medicine / 11 November 2020 US doctors failing to diagnose hepatitis C years after first signs of cirrhosis Keith Alcorn / 23 August 2019 Doctors are failing to test for hepatitis C in up to one in five people who have advanced liver disease despite many years of medical care, and these people are more likely ... Faecal transplants improve encephalopathy in people with advanced liver disease Liz Highleyman / 24 April 2019 Faecal microbiota transplantation (FMT), which helps restore a healthy mix of bacteria in the gut, can help reverse brain function impairment in people with liver failure, according to a report at the International ... What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... Gum disease treatment may improve symptoms in cirrhosis patients Eurekalert Medicine & Health / 29 August 2018 Fibroscan finds one in six people with hepatitis C in primary care have advanced liver disease Keith Alcorn / 28 August 2018 Measuring liver stiffness in primary care using Fibroscan is feasible and detects numerous cases of undiagnosed but advanced liver fibrosis, Australian researchers report in the journal BMJ Open this month. Despite availability of direct-acting ... Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows Michael Carter / 16 January 2018 Hepatitis C virus (HCV) treatment using direct-acting antivirals (DAAs) is highly effective and safe in harder-to-treat people with HIV co-infection, Spanish researchers report in AIDS. A sustained virological response (SVR), ... Cirrhosis linked to 30% of chronic HBV patients at initial presentation Healio Hepatology / 15 May 2017 Statins reduce risk of decompensation for people with HCV- and HBV-related cirrhosis Michael Carter / 18 April 2017 Treatment with statins reduces the risk of decompensated liver disease for people with cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), investigators from Taiwan report in the online edition ... ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive